Table 1. Baseline patients’ characteristics.
Variable | All patients (N=57) |
---|---|
Demographics | |
Age, years | 63.6±10.1 |
Gender, male | 39 (68.4) |
BMI, kg/m2 | 26±3.3 |
Risk factors & comorbidities | |
Peripheral vascular disease | 2 (3.5) |
Systemic hypertension | 43 (75.4) |
COPD | 10 (17.5) |
Renal failure | 17 (29.8) |
Diabetes mellitus | 7 (12.3) |
Pulmonary hypertension | 31 (54.4) |
Hyperlipidemia | 32 (56.1) |
Previous myocardial infarction | 4 (7.0) |
Previous stroke | 6 (10.5) |
Previous cardiac surgery | 2 (3.5) |
NYHA-classification | |
NYHA I-II | 41 (71.9) |
NYHA III-IV | 17 (29.8) |
Left ventricular ejection function | |
Normal (≥50%) | 50 (87.7) |
Impaired (<50%) | 7 (12.3) |
Risk-SCORES | |
STS-Prom for mortality | 1.4 (0.9–1.7) |
STS-Prom for morbidity & mortality | 13.4 (11–16.2) |
EuroSCORE log I | 5 (2.4–8.7) |
EuroSCORE II | 1.9 (1.3–2.1) |
Data presented as mean ± SD or number (%) or median and (IQR). BMI, body mass index; COPD, chronic obstructive pulmonary disease; NYHA-classification, New York Heart Association Classification; STS, Society of thoracic surgery; EuroSCORE, European system for cardiac operative risk evaluation.